All Activity

It looks like a creative and exciting project that highlights unique artistic expression and community. If you’re also into mobile gaming and fun downloads, feel free to visit my website: Geometrydashapk.net

With the Call Girls in Gurgaon, your evenings transform into enchanting hours filled with soft elegance and delightful company. These companions know how to bring calmness, charm, and natural warmth into your space, making you feel valued while creating an experience tailored beautifully to your comfort and emotional connection.

A quick search on any social media site reveals Women Cannabis Business Owners and Women’s Veterans Support Groups. I stumbled upon these incredible groups while sipping coffee, and it made me think, are these women reshaping the cannabis community with their compassion? AI Couple Photo

Four in five marijuana consumers say they oppose the recriminalization of hemp THC products under a spending bill President Donald Trump signed into law in November—weeks before he issued a cannabis rescheduling order and took steps to protect access to full-spectrum CBD. The current law as enacted, however, would redefine hemp in a way that industry stakeholders argue would effectively eradicate the sector that Trump legitimized during his first term when hemp was federally legalized under the 2018 Farm Bill. Though there’s been some splintering between marijuana and hemp interests over the THC ban, which is set to take effect next November, an overwhelming majority of cannabis consumers (82 percent) say they’re against the pending policy change. That’s according to a new poll from the cannabis telehealth platform NuggMD, which asked marijuana users to weigh in on the hemp THC recriminalization provisions of the law. Just 4 percent of respondents said they support the ban, while 15 percent said they don’t have an opinion about the policy. Q: “The president recently signed legislation that re-criminalizes hemp-derived THC, which was made legal in 2018. Do you support or oppose this policy?” n: % I oppose the policy. THC from hemp should be legal. 365 81.5% I don’t have an opinion on the policy. 67 15.0% I support the policy. THC from hemp should be prohibited. 16 3.6% The survey involved interviews with 448 cannabis consumers who live in state-legal markets from December 4-14, with a +/-4.63 percentage point margin of error. The poll was conducted weeks before Trump signed an executive order directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). Part of that announcement also hold implications for the forthcoming hemp law. The president’s executive order also urged Congress to examine updating the definition of hemp to ensure that full-spectrum CBD is accessible to patients. A further redefinition of hemp would be part of a novel proposal to allow Medicare recipients to access non-intoxicating CBD that’d be covered under the federal health care plan. To effectuate that, the Centers for Medicare & Medicaid Services (CMS) will be announcing “a model that will allow a number of CMS beneficiaries to benefit from receiving CBD under doctor recommendation at no cost,” a White House official said during a briefing that Marijuana Moment first reported leaked details from ahead of the signing event. “The December 18 Executive Order on cannabis makes it clear that the White House has a real CBD agenda,” Andrew Graham, communications director of NuggMD, told Marijuana Moment. “We polled the popularity of Congress’s latest efforts to regulate hemp because, right now, that policy is a major obstacle to that agenda.” “Cannabis consumers are the primary stakeholders in this policy debate because another ban on hemp THC affects them directly, so their voice belongs in the conversation,” he said. “Beyond that, there is also a practicality question about the ban, because I don’t know how you’d make federal policy that bans THC but does not ban CBD. Given the existing popularity of hemp THC products, this strikes me as a pick-a-lane situation and I won’t pretend to know which side will prevail.” Trump seemed endorse a more flexible CBD policy over the summer when he shared a video calling for that specific reform while promoting the health benefits of cannabidiol, particularly for seniors. Meanwhile, a recently filed Republican-led congressional bill would stop the implementation of the hemp ban under the enacted appropriations legislation. Hemp businesses and industry groups have warned about the potential ramifications of the ban, but despite his support for states’ rights for cannabis and a recent social media post touting the benefits of CBD, Trump signed the underlying spending measure into law without acknowledging the hemp provisions. GOP political operative Roger Stone said recently that Trump was effectively “forced” by Republican lawmakers to sign the spending bill with the hemp THC ban language. However, a White House spokesperson said prior to the bill signing that Trump specifically supported the prohibition language. The Democratic governor of Kentucky said that the hemp industry is an “important” part of the economy that deserves to be regulated at the state level—rather than federally prohibited, as Congress has moved to do. Also, a leading veterans organization is warning congressional leaders that the newly approved blanket ban on consumable hemp products could inadvertently “slam the door shut” on critical research. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Since 2018, cannabis products have been considered legal hemp if they contain less than 0.3 percent delta-9 THC on a dry weight basis. The new legislation specifies that, within one year of enactment, the weight will apply to total THC—including delta-8 and other isomers. It will also include “any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).” The new definition of legal hemp will additionally ban “any intermediate hemp-derived cannabinoid products which are marketed or sold as a final product or directly to an end consumer for personal or household use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or not capable of being naturally produced by it. Legal hemp products will be limited to a total of 0.4 milligrams per container of total THC or any other cannabinoids with similar effects. Within 90 days of the bill’s enactment, the Food and Drug Administration (FDA) and other agencies will need to publish list of “all cannabinoids known to FDA to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature,” “all tetrahydrocannabinol class cannabinoids known to the agency to be naturally occurring in the plant” and “all other known cannabinoids with similar effects to, or marketed to have similar effects to, tetrahyrocannabinol class cannabinoids.” The language slightly differs from provisions included in legislation that had previously advanced out of the House and Senate Appropriations panels, which would have banned products containing any “quantifiable” amount of THC, to be determined by the HHS secretary and secretary of agriculture. The post 4 In 5 Marijuana Consumers Oppose Hemp THC Ban Trump Signed Ahead Of Rescheduling And CBD Access Order, Poll Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Democratic congressman is accusing a top GOP colleague of attempting to “invalidate thousands of lawful pardons” that former President Joe Biden issued to people who’ve committed federal marijuana possession offenses. Rep. Jerrold Nadler (D-NY)–the lead sponsor of a cannabis legalization bill called the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act—responded to comments from House Oversight and Government Reform Committee Chairman James Comer (R-KY), who applauded President Donald Trump’s recent cannabis rescheduling order and recognized racial disparities in marijuana enforcement. Comer said that there’s evidence of “injustice” in cannabis prohibition, stating that a person can “make the argument that it’s racist” given that “there aren’t many people that aren’t minorities that are in prison for marijuana possession.” He made similar remarks in September. Nadler, who previously chaired the House Judiciary Committee said his colleague is “right” that there’s “deep injustice in how our outdated marijuana laws have been enforced.” However, he said, simply moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) as Trump’s order directs the attorney general to do “won’t end federal criminal penalties, won’t expunge records, and won’t free people still imprisoned solely for low-level marijuana offenses.” My colleague is right, there is a deep injustice in how our outdated marijuana laws have been enforced. But rescheduling won’t end federal criminal penalties, won’t expunge records, and won’t free people still imprisoned solely for low-level marijuana offenses. If Chair Comer… https://t.co/Vrf0ZaT9Qv — Rep. Nadler (@RepJerryNadler) December 16, 2025 “If Chair Comer wants to help end this injustice, I invite him to cosponsor my MORE Act, which would decriminalize marijuana and begin repairing the harm these policies have caused,” Nadler said, referring to his bill that passed the House twice under Democratic majorities. He added that he’d urge Comer to “stop trying to invalidate thousands of lawful pardons granted to people convicted of low-level marijuana offenses.” That latter point raised some eyebrows, especially given Comer’s relative openness to cannabis reform compared to many of his GOP colleagues. But it appears to be related to a broader committee investigation into Biden’s use of an “autopen” to approve clemency actions without personally signing each individual order. The chairman hasn’t said it’s his intention to invalidate the cannabis pardons, but Nadler evidently believes they could be caught up in the broader review into the former president’s pardon actions. Marijuana Moment reached out to Nadler’s office about the issue, and a staffer shared a copy of the committee report titled “The Biden Autopen Presidency,” acknowledging that while it “focuses heavily on President Biden’s pardons issued toward the end of his Administration, it goes much farther.” “The report states that if an executive action was signed via autopen without clear written proof that the President personally approved it, the action shouldn’t count,” the staffer said. “It also calls on the Justice Department to review ALL of President Biden’s executive actions, particularly clemency actions, to determine whether any should be undone.” As part of the investigation, the committee also cited comments from several former Biden staffers who shed light on the mass marijuana pardons and cannabis rescheduling process they helped facilitate, revealing the extent to which they were involved in broader clemency actions that are under scrutiny by GOP leaders. Again, whether the cannabis clemency actions could be reversed as part of a broader review into the “autopen” issue remains to be seen. President Donald Trump during his first term issued various drug-related pardons and has said he doesn’t feel people should be in jail over simple marijuana possession. What’s more, altering the cannabis clemency record of the Biden administration would seem to be at odds with Trump’s recent executive order directing the attorney general to expeditiously complete the marijuana rescheduling process. But while Nadler argued that Comer could better address enforcement disparities by supporting his MORE Act, the chances of that legislation passing under the Republican-controlled Congress is doubtful. Comer’s own position is that, while it seems apparent that there’s racial bias in cannabis criminalization, Democrats’ more sweeping proposals to promote equity as part of a legalization plan go too far. Comer’s office did not respond to Marijuana Moment’s requests for comment for this story. Photo courtesy of Chris Wallis // Side Pocket Images. The post GOP Committee Chair Wants To ‘Invalidate’ Biden’s Marijuana Pardons Through Autopen Investigation, Democratic Congressman Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“If cannabis is medicine, why is the system built as if it were only a retail commodity?” By Jordan Tishler, MD, Association of Cannabinoid Specialists Currently, medical cannabis programs across the United States are dwindling. This is directly a result of these programs being deprioritized in favor of recreational programs and being regulated in a manner that neither provides support to clinicians to do their jobs, nor value to patients who need safe, effective products and expert medical guidance to achieve benefit. Among the many problems baked into these medical cannabis programs, the financial requirements to become a medical dispensary actually disincentivize dispensaries from participating. States must overhaul cannabis rules to make it feasible—and attractive—for dispensaries to prioritize medical patients instead of treating them as an afterthought in a recreational market. What Eastham Shows Us A recent article in the Provincetown Independent discusses the issues confronting the owners of a dispensary in Eastham, Massachusetts who have decided to swim upstream and apply for a medical license—a truly rare occurrence these days. It has to be asked why new medical dispensaries are so rarely opened these days. In fact, Massachusetts has lost a significant number of medical dispensaries in the past year. Emerald Grove’s plan to add medical marijuana services, in a market crowded with recreational options, has been stymied by out-of-date and disincentivizing state regulation. The article notes that critics of state rules argue that a shift toward prioritizing medicinal use is needed, underscoring that current policy treats medical access as incidental to the non-therapeutic (aka recreational) industry rather than as a core public health service. Medical patients on the Outer Cape, like elsewhere in Massachusetts, often travel long distances or navigate complex systems to find knowledgeable clinicians, consistent products and medically oriented counseling—needs that are not reliably met in a purely recreational framework. When a single dispensary’s decision to add medical services becomes newsworthy, that is not a sign of healthy access; it is a red flag that the system is failing patients. How Current Rules Undermine Medical Care From the perspective of practicing cannabinoid medicine, several regulatory features consistently undermine the development of robust medical programs. These include: Licensing structures that treat medical service as an optional add-on to recreational stores, rather than as a distinct health-care function with its own standards and incentives. Fees and tax policies that make medical operations financially marginal compared with recreational sales, pushing operators to focus on tourists and high-volume nonmedical consumers. Lack of tax and other incentives to consumers to encourage them to seek medical care for their illnesses. Current incentives only encourage high volume users to seek “certification” in order to obtain excessive amounts of product. Lack of mandated prescribing by trained cannabinoid clinicians, so “medical” offerings are often little more than branding, with no real clinical guidance or follow-up. Association of Cannabinoid Specialists (ACS) was founded precisely because patients are uniquely vulnerable in this space and have very different needs from recreational users. When regulations blur or ignore that distinction, patients with cancer, chronic pain, PTSD, and other conditions are left to self-experiment under the guise of “advice” from untrained retail staff. What Patients Actually Need For cannabis to function as medicine, patients need access not just to products, but to a system designed around clinical care. That means: Dispensaries that commit to medical programs with binding prescriptions, documentation standards and coordination with the patient’s Cannabinoid Specialist clinicians. Clinicians who understand dosing paradigms, interactions and risk mitigation, and who can tailor regimens to complex comorbidities. Product lines that are consistent, labeled to medical standards and available reliably over time so that titration and monitoring are meaningful. States that treat cannabis primarily as a tax-revenue generator will not get this kind of system by accident. It must be built intentionally through regulation that privileges patient care over volume sales. Regulatory Changes States Should Enact From ACS’s perspective, several concrete reforms are essential if states want medical dispensaries like the one in Eastham to flourish rather than watching these programs dwindle and disappear. Key changes include: Maintaining distinct medical licenses with fees reduced below those of recreational stores, streamlined applications and regulatory stability in exchange for meeting higher clinical standards. Requiring formal prescriptions to be written by qualified cannabinoid clinicians, including written care protocols and documented patient education, and requiring that licensed medical dispensaries honor those prescriptions without modification or addition. Establishing product standards and testing tailored to medical use, such as tighter tolerances on labeled cannabinoid content and clear guidance on excipients. Further, such products must always be available to patients. These are not theoretical tweaks; they are practical tools for building a stable ecosystem in which operators have a reason to invest in medical services instead of quietly abandoning them when margins tighten. A Call to Lawmakers and Regulators The Eastham example should prompt state policymakers to ask a simple question: if cannabis is medicine, why is the system built as if it were only a retail commodity? Legislators, regulators and municipal officials must partner with organizations like ACS to redesign rules so that medical care is not a side project of the recreational industry, but its own pillar of the health-care system. Patients deserve access to knowledgeable clinicians, medically focused dispensaries and products that support real treatment, not just trial-and-error self-use. States that are willing to revise their regulations accordingly will see more Emerald Groves choosing to offer true medical cannabis services—and more patients getting the care they were promised when medical legalization first passed. Jordan Tishler, MD is the president of the Association of Cannabinoid Specialists. The post Patients Need More Medically Focused Cannabis Dispensaries (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The U.S. Department of Agriculture (USDA) is defending its decision to adopt a rule adding restrictions on companies that provide services to marijuana businesses, making it so participants in a particular government loan guarantee program are prohibited from receiving income from cannabis operations. After posting the finalized rule in October 2024—amending a guaranteed loan program called OneRD through USDA’s Rural Utilities Service—the agency published a notice in the Federal Register last month responding to comments on the marijuana-related policy change. Regarding cannabis, the rule bars lenders from working with an entity “if it derives income from illegal drugs, drug paraphernalia, or any other illegal product or activity as defined under Federal statute.” “A borrower that intends to lease space or enter into a power purchase agreement with a marijuana dispensary is not eligible,” the rule says, “given our borrower would be receiving income from the marijuana operation which is a violation of Federal laws as marijuana is a controlled substance under Federal law and subject to Federal prosecution under the Controlled Substances Act (21 U.S.C. 812).” USDA said in the latest notice that all four people who comments on the rule “indicated disagreement with the Agency’s decision to prohibit an entity that receives income from marijuana operations from receiving Agency assistance.” “The Agency is aware that many states have legalized the production and sale of marijuana; however, marijuana is currently listed as a schedule I substance under the Controlled Substances Act,” it said. “As noted in the regulation any entity that derives income from illegal drugs, drug paraphernalia, or any other illegal product or activity are ineligible under Federal Statute.” “No change to the rulemaking is necessary,” it said. “The Agency appreciates the comments received. The Agency confirms the final rule without change.” It’s unclear whether the rule could be impacted if the attorney general follows through with President Donald Trump’s recent executive order directing the completion of a process to move marijuana from Schedule I to Schedule III of the CSA. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, although the USDA rule is another reminder of the complications around the state–federal conflict on marijuana laws, the agency has been working to bolster the hemp industry since the legalization of that crop through the 2018 Farm Bill, including by appointing a number of industry stakeholders to a federal trade advisory committee that’s meant to support efforts to promote U.S.-grown cannabis around the world. It also remains to be seen how the department will navigate a newly enacted law reimposing a federal ban on most consumable hemp products, which is the most profitable sector of the market. In addition to directing marijuana rescheduling, Trump also took steps to remediate that policy change, which is currently set to be implemented next November. Specifically, he called for access to full-spectrum CBD products. The president said the cannabinoid holds therapeutic potential and should be covered for certain patients under Medicare. Photo courtesy of Philip Steffan. The post Feds Defend Decision To Block Companies That Work With Marijuana Industry From Participating In Loan Program appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

That is the excellent mindset, nonetheless is just not help to make every sence whatsoever preaching about that mather. Virtually any method many thanks in addition to i had endeavor to promote your own article in to delicius nevertheless it is apparently a dilemma using your information sites can you please recheck the idea. thanks once more. pool covers

It was a very good post indeed. I thoroughly enjoyed reading it in my lunch time. Will surely come and visit this blog more often. Thanks for sharing. https://www.coachandbusmarket.com/wp-content/pgs/melbet_today_promo_code.html

This was really an interesting topic and I kinda agree with what you have mentioned here! swimming pool covers

This is my first time visit here. From the tons of comments on your articles,I guess I am not only one having all the enjoyment right here! Designer pool covers

This was a really great contest and hopefully I can attend the next one. It was alot of fun and I really enjoyed myself.. https://cascadeclimbers.com/content/pgs/888starz_promo_code____vip_bonus_.html

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free. Designer pool covers

thanks for this usefull article, waiting for this article like this again. https://anthese.fr/img/pgs/code_promo_linebet_bonus_de_bienvenue.html

i never know the use of adobe shadow until i saw this post. thank you for this! this is very helpful. swimming pool covers

I think this is an informative post and it is very useful and knowledgeable. therefore, I would like to thank you for the efforts you have made in writing this article. Designer pool covers

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free. https://kalicrack.com/pgs/888starz-promo-code_and_bonus-code.html

It is a good site post without fail. Not too many people would actually, the way you just did. I am impressed that there is so much information about this subject that has been uncovered and you’ve defeated yourself this time, with so much quality. Good Works! Designer pool covers

FL medical marijuana expansion; New ad cheers Trump’s rescheduling move; OH gov slams cannabis referendum; NJ medical marijuana patient count drops Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Danny Brown: “Your timely and accurate reporting are the best in the industry. It takes me ten minutes and I am all caught up on the latest cannabis news.” Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Pennsylvania’s House speaker said legalizing marijuana could help to generate “very important” revenue for the state if only lawmakers have “the will to do it”—noting that the Senate has so far refused to join her chamber in passing legislation to end cannabis prohibition. A Florida senator filed a bill to expand medical cannabis access by waiving registration fees for military veterans, making patient registrations last twice as long and increasing smokable marijuana supply limits. America First Agriculture, Inc.—a group connected to a political action committee sharing the same treasurer as President Donald Trump’s MAGA Inc. super PAC—launched a new ad applauding his marijuana rescheduling order, arguing it’ll “destroy” the illicit market and support seniors and military veterans who could benefit from cannabis. Ohio Gov. Mike DeWine’s (R) office and a GOP senator are criticizing a citizen-led cannabis referendum campaign that seeks to reverse lawmakers’ move to recriminalize certain marijuana activity and restrict hemp products. The New Jersey Cannabis Regulatory Commission reports that the state’s number of registered medical marijuana patients has dropped 20 percent since the beginning of 2025. / FEDERAL An analysis of the wreckage of an alleged drug boat destroyed by Trump administration military strikes found that “most packets were empty, though traces of a substance that looked and smelled like marijuana were found in the lining of a few.” The Drug Enforcement Administration is promoting drug facts to “prevent misuse, avoid harmful interactions, and recognize warning signs early to help those in need.” The Congressional Research Service published updated reports on changes to the federal definition of hemp. Former Rep. Matt Gaetz (R-FL) discussed marijuana and hemp with Tucker Carlson. / STATES A Tennessee representative plans to file a bill to legalize marijuana possession and home cultivation in the 2026 session. A former Delaware judge authored an op-ed arguing that it would make more sense to move marijuana to Schedule II rather than Schedule III. Florida regulators adopted changes to medical cannabis rules. California regulators are moving to change cannabis cultivation and minimum sanitation standard rules. Michigan regulators published updated guidance on a newly approved marijuana tax increase. Colorado regulators published guidance on cannabis business research and development units. Minnesota cannabis regulators sent a reminder about the deadline to apply for a community restoration grant program. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL The Cayman Islands Law Reform Commission hasn’t acted on marijuana decriminalization months after voters approved a referendum supporting the reform. / SCIENCE & HEALTH A study found that “legalization reduces but does not eliminate illicit THC sales.“ A study of fibromyalgia patients found “an association between treatment with [cannabis-based medicinal products] and improvements in pain, anxiety, sleep, and general quality of life.” / ADVOCACY, OPINION & ANALYSIS The Dallas Morning News editorial board says there is “weak evidence on medical benefits” of marijuana, “but more on its dangers.” / BUSINESS Organigram Global Inc. is expanding its investment in Phylos Bioscience Inc. AYR Wellness Inc.’s interim chief financial officer is leaving the company. The former chairman of Hightimes Holding Corp. wrote in an op-ed that cannabis reform should be accompanied by “an honest conversation about addiction.” / CULTURE Paul McCartney visited the marijuana dispensary owned by Bill Maher and Woody Harrelson, Maher said. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Max Jackson. The post Pennsylvania should legalize cannabis, top lawmaker says (Newsletter: January 1, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

New users can enter the 1xBet Promo Code 1XWAP200 to get a 100% bonus up to $130 and 150 Free spins no deposit – a set number of spins credited after registration, verification or promo code activation. A free bet from 1xbet promo code - how to use free bet in 1xbet - promo code in 1 xbet accumulator enter the number of bonus points you want to spend and press the "Get code" or "Get a game" button 1xbet free promo code today pakistan

Great job for publishing such a beneficial web site. Your web log isn’t only useful but it is additionally really creative too. 대구 출장마사지 Great job for publishing such a beneficial web site. Your web log isn’t only useful but it is additionally really creative too. slot gacor Great job for publishing such a beneficial web site. Your web log isn’t only useful but it is additionally really creative too. bandar slot gacor Great job for publishing such a beneficial web site. Your web log isn’t only useful but it is additionally really creative too. 給湯器交換 おすすめ

Укажите наш промокод 1xBet – 1X200NUT и выберите приветственный бонус. 1хбет промокод при регистрации

I found that site very usefull and this survey is very cirious, I ' ve never seen a blog that demand a survey for this actions, very curious... 대구 출장마사지 I found that site very usefull and this survey is very cirious, I ' ve never seen a blog that demand a survey for this actions, very curious... slot depo 5k I found that site very usefull and this survey is very cirious, I ' ve never seen a blog that demand a survey for this actions, very curious... slot gacor I found that site very usefull and this survey is very cirious, I ' ve never seen a blog that demand a survey for this actions, very curious... エコキュート 補助金

Most other states allow people to grow their own marijuana at home, particularly medical marijuana users, while New Jersey still fully bans it. By Sophie Nieto-Muñoz, New Jersey Monitor New Jersey’s steep decline in medical marijuana patients continued with another 20 percent drop since the beginning of 2025. Between January and December, roughly 14,000 people let their medical marijuana registration lapse, a trend that has continued since the recreational market launched in April 2022. As of mid-December, 51,776 people are registered medical marijuana patients, according to the state Cannabis Regulatory Commission. In June 2022, that figure was nearly 130,000. Medical marijuana cardholders get some benefits. Dispensaries hold patient-only hours, give patients special parking, and let them skip ahead of recreational users in line. Patients also avoid paying cannabis taxes and can purchase up to 3 ounces of cannabis per month. Before the recreational market opened, patients were the only New Jerseyans who could legally buy marijuana. In recent years, officials have attempted to attract people back to the medical program by dropping the price of a registration card from $200 to $10 (there’s also a free digital option). People must also obtain a card from doctors who qualify to write medical cannabis prescriptions for treatment of conditions like epilepsy, post-traumatic stress disorder, anxiety, cancer and more. The drop in enrollment has reflected the trends other states have seen when launching adult-use weed. But most other states allow people to grow their own marijuana at home, particularly medical marijuana users, while New Jersey still fully bans it. This story was first published by New Jersey Monitor. The post New Jersey Medical Marijuana Program Sees Steep Drop In Registered Patients appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Florida Republican senator has filed a bill to expand the state’s medical marijuana program, in part by increasing supply limits for patients and waiving registration fees for honorably discharged military veterans. The legislation from Sen. Alexis Calatayud (R), filed for the 2026 session on Tuesday, would also make it so medical cannabis registrations could last up to two years instead of the current 30 weeks. Another section of the bill stipulates that doctors could certify patients to receive up to 10 70-day supply limits of smokable medical marijuana, rather than three. They could also issue up to 20 35-day supply limits instead of the current six. A similar version of legislation was introduced in the House by Rep. Bill Partington (R) earlier this month. That bill additionally called for reciprocity in the program, requiring regulators to create a process to issue medical cannabis registration cards to “nonresidents who are actively enrolled in the medical cannabis program of another jurisdiction recognized by the department within 1 business day.” It specifies that “a visiting qualified patient may engage in all conduct authorized for a qualified patient.” It would also allow doctors to recommend cannabis to any patient who has a condition for which they have been prescribed opioids. Another provision of the House bill absent from the new Senate version would allow doctors to recommend medical cannabis via telehealth without a physical examination—expanding a current policy that allows renewals, but not initial certifications, to be conducted remotely. Other recently filed bills in the legislature for 2026 would reduce medical cannabis patient registration fees for military veterans and clarify that smoking or vaping marijuana in public places is prohibited. Meanwhile, a Florida Democratic senator introduced legislation for the 2026 session that would legalize home cultivation of marijuana for registered medical cannabis patients in the state. The proposal would permit qualified patients who are at least 21 years old to cultivate up to six flowering plants for personal, therapeutic use. Those patients could also buy seeds and clones from licensed dispensaries. If enacted into law, the bill would become law on July 1, 2026. A similar proposal was introduced at the beginning of this year by Sen. Joe Gruters (R), who is now chairman of the Republican National Committee, but it did not advance. Gruters and Kim Rivers—the CEO of Trulieve, a medical marijuana company that provided the bulk of funding for an unsuccessful cannabis legalization ballot initiative last year—also met with President Donald Trump ahead of his endorsement of the constitutional amendment, as well as federal rescheduling and industry banking access. The campaign behind that initiative, Smart & Safe Florida, recently said it’s collected more than one million signatures to put a new version of the legalization measure on the 2026 ballot. But the signature gathering process has hit multiple snags that have led to litigation, including a new lawsuit filed by activists challenging the state’s decision to invalidate another 71,000 signatures over issues related to “inactive” voters and out-of-state petitioners. This comes after another court upheld a previous decision to strike about 200,000 signatures that the state said were invalid because the petitions didn’t include the full text of the proposed initiative. The campaign contested the legal interpretation, but it declined to appeal the decision based on their confidence they’d collected enough signatures to make up the difference. Now, with a February 1 deadline to submit 880,062 valid signatures just about a month away, Smart & Safe Florida is signaling that the additional invalidations could jeopardize their chances of making the ballot. Currently, the state has validated 675,307 signatures. Meanwhile, earlier this month, Florida’s attorney general asked the state Supreme Court to review the constitutionality of the legalization initiative. The court accepted the request and set a schedule for state officials and the cannabis campaign to file briefs next month. Florida Gov. Ron DeSantis (R) campaigned heavily against an earlier version of the legalization proposal, which received a majority of voters last year but not enough to meet the 60 percent threshold required to pass a constitutional amendment. Former Attorney General Ashley Moody (R) unsuccessfully contested the prior initiative in the courts. In March, meanwhile, two Democratic members of Congress representing Florida asked the federal government to investigate what they described as “potentially unlawful diversion” of millions in state Medicaid funds via a group with ties to Gov. Ron DeSantis (R). The money was used to fight against a citizen ballot initiative, vehemently opposed by the governor, that would have legalized marijuana for adults. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In the background, a recent poll from a Trump-affiliated research firm found that nearly 9 in 10 Florida voters say they should have the right to decide to legalize marijuana in the state. Meanwhile, a pro-legalization GOP state lawmaker recently filed a bill to amend state law to codify that the public use of marijuana is prohibited. Rep. Alex Andrade (R), the sponsor, said earlier this year that embracing cannabis reform is a way for the Republican party to secure more votes from young people. Separately, Florida medical marijuana officials are actively revoking the registrations of patients and caregivers with drug-related criminal records. The policy is part of broad budget legislation signed into law earlier this year by DeSantis. The provisions in question direct the state Department of Health (DOH) to cancel registrations of medical marijuana patients and caregivers if they’re convicted of—or plead guilty or no contest to—criminal drug charges. Photo courtesy of Brian Shamblen. The post Florida GOP Senator’s Bill Would Expand Medical Marijuana Law By Waiving Fees For Veterans And Making Patient Cards Last Twice As Long appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net